ID: ALA175042

Max Phase: Preclinical

Molecular Formula: C23H22N2O3

Molecular Weight: 374.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1c2ccccc2c2c3c(cccc13)C(=O)C(CCN(C)C)C2=O

Standard InChI:  InChI=1S/C23H22N2O3/c1-13(26)24-21-15-8-5-4-7-14(15)20-19-16(21)9-6-10-17(19)22(27)18(23(20)28)11-12-25(2)3/h4-10,18H,11-12H2,1-3H3,(H,24,26)

Standard InChI Key:  ZXXHVPGSHYJQCC-UHFFFAOYSA-N

Associated Targets(Human)

UACC-375 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

OVCAR-3 48710 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1630AlogP: 3.90#Rotatable Bonds: 4
Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.46CX Basic pKa: 8.23CX LogP: 2.68CX LogD: 1.76
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: -0.01

References

1. Sami SM, Dorr RT, Sólyom AM, Alberts DS, Remers WA..  (1995)  Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.,  38  (6): [PMID:7699715] [10.1021/jm00006a018]

Source